Srdjan R. Stankovic - 15 Oct 2021 Form 4 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
President
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Issuer symbol
ACAD
Transactions as of
15 Oct 2021
Transactions value $
-$23,295
Form type
4
Filing time
19 Oct 2021, 17:31:19 UTC
Next filing
23 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACAD Common Stock Options Exercise +2.97K +8.15% 39.4K 15 Oct 2021 Direct F1
transaction ACAD Common Stock Sale -$23.3K -1.34K -3.4% $17.41 38.1K 18 Oct 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACAD Restricted Stock Units Options Exercise $0 -2.97K -50% $0.00 2.97K 15 Oct 2021 Common Stock 2.97K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
F3 The restricted stock units vest in four equal annual installments beginning 10/15/19.